Ratings by Oppenheimer (Kevin DeGeeter)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/27/2021 Rezolute RZLT New Coverage Outperform
(N/A)
7.69
(12.45)
61.9% Details
5/14/2021 9 Meter Biopharma NMTR Maintain Outperform
(N/A)
 
 
  Details
5/7/2021 Humanigen HGEN New Coverage Outperform
(N/A)
19.02
(19.00)
-0.11% Details
5/6/2021 Personalis PSNL Upgrade Outperform
(Perform)
21.64
(25.45)
17.61% Details
4/30/2021 Cyclacel Pharmaceuticals CYCC New Coverage Outperform
(N/A)
7.23
(6.24)
-13.69% Details
4/15/2021 Molecular Templates MTEM Maintain Outperform
(N/A)
 
 
  Details
4/12/2021 Taysha Gene Therapies TSHA Maintain Outperform
(N/A)
 
 
  Details
4/7/2021 Fulgent Genetics FLGT Maintain Outperform
(N/A)
 
 
  Details
4/5/2021 Invitae Corporation NVTA Upgrade Outperform
(Perform)
39.19
(33.34)
-14.93% Details
3/23/2021 Ionis Pharmaceuticals IONS Maintain Outperform
(N/A)
 
 
  Details
3/12/2021 Spero Therapeutics SPRO Maintain Outperform
(N/A)
 
 
  Details
3/5/2021 DermTech Inc. DMTK Maintain Outperform
(N/A)
 
 
  Details
3/2/2021 Evaxion Biotech EVAX New Coverage Outperform
(N/A)
7.08
(6.14)
-13.28% Details
3/1/2021 Sensei Biotherapeutics SNSE New Coverage Outperform
(N/A)
16.50
(11.13)
-32.55% Details
2/25/2021 Ionis Pharmaceuticals IONS Maintain Outperform
(N/A)
 
 
  Details
2/11/2021 Infinity Pharmaceutical INFI Maintain Outperform
(N/A)
 
 
  Details
2/10/2021 Orchard Therapeutics ORTX Maintain Outperform
(N/A)
 
 
  Details
2/8/2021 Bionano Genomics BNGO Maintain Outperform
(N/A)
 
 
  Details
2/5/2021 Infinity Pharmaceutical INFI Maintain Outperform
(N/A)
 
 
  Details
2/4/2021 Moleculin Biotech MBRX Maintain Outperform
(N/A)
 
 
  Details
2/1/2021 Fulgent Genetics FLGT Maintain Outperform
(N/A)
 
 
  Details
2/1/2021 Invitae Corporation NVTA Downgrade Perform
(Outperform)
50.93
(33.34)
-34.54% Details
1/29/2021 9 Meter Biopharma NMTR New Coverage Outperform
(N/A)
1.11
(1.40)
26.13% Details
1/22/2021 DermTech Inc. DMTK New Coverage Outperform
(N/A)
43.75
(42.81)
-2.15% Details
1/13/2021 Vascular Biogenics Ltd VBLT Maintain Outperform
(N/A)
 
 
  Details
1/12/2021 Invitae Corporation NVTA Maintain Outperform
(N/A)
 
 
  Details
1/11/2021 Vericel Corporation VCEL Downgrade Perform
(Outperform)
36.17
(61.23)
69.28% Details
1/5/2021 Spero Therapeutics SPRO Maintain Outperform
(N/A)
 
 
  Details
1/5/2021 Taysha Gene Therapies TSHA New Coverage Outperform
(N/A)
26.54
(25.94)
-2.26% Details
12/31/2020 Fulgent Genetics FLGT Maintain Outperform
(N/A)
 
 
  Details
12/28/2020 Cellectar Biosciences CLRB Maintain Outperform
(N/A)
 
 
  Details
12/8/2020 Rocket Pharmaceuticals RCKT Downgrade Perform
(Outperform)
32.08
(43.63)
36% Details
11/6/2020 Personalis PSNL Downgrade Perform
(Outperform)
26.38
(25.45)
-3.53% Details
11/5/2020 Ionis Pharmaceuticals IONS Maintain Outperform
(N/A)
 
 
  Details
10/5/2020 Fulgent Genetics FLGT Maintain Outperform
(N/A)
 
 
  Details
9/22/2020 Rocket Pharmaceuticals RCKT Maintain Outperform
(N/A)
 
 
  Details
9/14/2020 Orchard Therapeutics ORTX Maintain Outperform
(N/A)
 
 
  Details
8/20/2020 Fulgent Genetics FLGT New Coverage Outperform
(N/A)
44.01
(78.77)
78.98% Details
8/17/2020 Personalis PSNL Maintain Outperform
(N/A)
 
 
  Details
8/7/2020 Molecular Templates MTEM Maintain Outperform
(N/A)
 
 
  Details
7/27/2020 Bionano Genomics BNGO Maintain Outperform
(N/A)
 
 
  Details
7/22/2020 Invitae Corporation NVTA Maintain Outperform
(N/A)
 
 
  Details
6/16/2020 Ideaya Biosciences IDYA Maintain Outperform
(N/A)
 
 
  Details
6/1/2020 Rocket Pharmaceuticals RCKT New Coverage Outperform
(N/A)
18.81
(43.63)
131.95% Details
6/1/2020 NovoCure Ltd. NVCR New Coverage Outperform
(N/A)
67.43
(220.52)
227.04% Details
6/1/2020 Orchard Therapeutics ORTX New Coverage Outperform
(N/A)
9.50
(4.79)
-49.58% Details
6/1/2020 Ionis Pharmaceuticals IONS New Coverage Outperform
(N/A)
56.21
(36.91)
-34.34% Details
5/12/2020 Novavax NVAX Maintain Outperform
(N/A)
 
 
  Details
5/12/2020 Molecular Templates MTEM Maintain Outperform
(N/A)
 
 
  Details
5/1/2020 PolarityTE PTE Downgrade Perform
(Outperform)
1.09
(1.06)
-2.75% Details
4/17/2020 Vascular Biogenics Ltd VBLT Maintain Outperform
(N/A)
 
 
  Details
4/8/2020 Bionano Genomics BNGO New Coverage Outperform
(N/A)
0.28
(7.22)
2478.57% Details
4/2/2020 Invitae Corporation NVTA Maintain Outperform
(N/A)
 
 
  Details
3/26/2020 Personalis PSNL Maintain Outperform
(N/A)
 
 
  Details
2/24/2020 PolarityTE PTE Maintain Outperform
(N/A)
 
 
  Details
1/13/2020 Invitae Corporation NVTA Maintain Outperform
(N/A)
 
 
  Details
12/16/2019 Athenex ATNX Maintain Outperform
(N/A)
 
 
  Details
11/14/2019 Personalis PSNL Maintain Outperform
(N/A)
 
 
  Details
10/17/2019 Moleculin Biotech MBRX New Coverage Outperform
(N/A)
1.02
(3.60)
252.94% Details
10/17/2019 Ideaya Biosciences IDYA New Coverage Outperform
(N/A)
6.50
(22.52)
246.46% Details
10/2/2019 Spero Therapeutics SPRO Maintain Outperform
(N/A)
 
 
  Details
9/10/2019 Novavax NVAX Maintain Outperform
(N/A)
 
 
  Details
8/21/2019 PolarityTE PTE Maintain Outperform
(N/A)
 
 
  Details
8/9/2019 PolarityTE PTE Maintain Outperform
(N/A)
 
 
  Details
8/7/2019 Invitae Corporation NVTA Maintain Outperform
(N/A)
 
 
  Details
6/27/2019 Infinity Pharmaceutical INFI New Coverage Outperform
(N/A)
1.69
(3.33)
97.04% Details
6/27/2019 Vascular Biogenics Ltd VBLT New Coverage Outperform
(N/A)
1.19
(2.27)
90.76% Details
6/6/2019 Cidara Therapeutics CDTX New Coverage Outperform
(N/A)
1.52
(2.00)
31.58% Details
5/13/2019 Novavax NVAX Maintain Outperform
(N/A)
 
 
  Details
5/7/2019 Vericel Corporation VCEL Maintain Outperform
(N/A)
 
 
  Details
5/2/2019 Athenex ATNX New Coverage Outperform
(N/A)
9.88
(4.71)
-52.33% Details
4/8/2019 PolarityTE PTE Maintain Outperform
(N/A)
 
 
  Details
4/8/2019 Invitae Corporation NVTA Maintain Outperform
(N/A)
 
 
  Details
3/29/2019 PolarityTE PTE Maintain Outperform
(N/A)
 
 
  Details
3/19/2019 Novavax NVAX Maintain Outperform
(N/A)
 
 
  Details
3/8/2019 Vericel Corporation VCEL Maintain Outperform
(Outperform)
 
 
  Details
3/1/2019 Novavax NVAX Maintain Outperform
(N/A)
 
 
  Details
2/22/2019 Neon Therapeutics NTGN Maintain Outperform
(N/A)
 
 
  Details
1/29/2019 Vericel Corporation VCEL New Coverage Outperform
(N/A)
17.30
(61.23)
253.93% Details
1/29/2019 PolarityTE PTE New Coverage Outperform
(N/A)
17.00
(1.09)
-93.59% Details
1/4/2019 Catalyst Biosciences CBIO New Coverage Outperform
(N/A)
8.25
(4.18)
-49.33% Details
1/4/2019 Neon Therapeutics NTGN New Coverage Outperform
(N/A)
5.05
(3.07)
-39.21% Details
12/19/2018 Genomic Health Inc. GHDX New Coverage Perform
(N/A)
65.97
(63.44)
-3.84% Details
12/19/2018 Invitae Corporation NVTA New Coverage Outperform
(N/A)
11.00
(33.34)
203.09% Details
12/11/2018 Molecular Templates MTEM New Coverage Outperform
(N/A)
4.39
(8.51)
93.85% Details
12/11/2018 BioTime, Inc. BTX New Coverage Outperform
(N/A)
1.34
(16.10)
1101.49% Details
12/11/2018 Novavax NVAX New Coverage Outperform
(N/A)
2.05
(180.99)
8728.78% Details